Harmony Biosciences Holdings Inc
NASDAQ:HRMY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Harmony Biosciences Holdings Inc
NASDAQ:HRMY
|
US |
|
NDR Auto Components Ltd
NSE:NDRAUTO
|
IN |
|
Zhejiang Meorient Commerce & Exhibition Inc
SZSE:300795
|
CN |
|
Tokyo Board Industries Co Ltd
TSE:7815
|
JP |
|
T
|
Tanco Holdings Bhd
KLSE:TANCO
|
MY |
|
Victoria Care Indonesia Tbk PT
IDX:VICI
|
ID |
|
Zignago Vetro SpA
MIL:ZV
|
IT |
|
Taiwan Pelican Express Co Ltd
TWSE:2642
|
TW |
Wall Street
Price Targets
HRMY Price Targets Summary
Harmony Biosciences Holdings Inc
According to Wall Street analysts, the average 1-year price target for
HRMY
is 46.55 USD
with a low forecast of 31.31 USD and a high forecast of 65.1 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HRMY's stock price target?
Price Target
46.55
USD
According to Wall Street analysts, the average 1-year price target for
HRMY
is 46.55 USD
with a low forecast of 31.31 USD and a high forecast of 65.1 USD.
What is Harmony Biosciences Holdings Inc's Revenue forecast?
Projected CAGR
15%
For the last 6 years the
compound annual growth rate for
Harmony Biosciences Holdings Inc's revenue is
129%.
The projected
CAGR
for the next 3 years is
15%.
What is Harmony Biosciences Holdings Inc's Operating Income forecast?
Projected CAGR
29%
The
compound annual growth rate
of Harmony Biosciences Holdings Inc's operating income for the next 3 years is
29%.
What is Harmony Biosciences Holdings Inc's Net Income forecast?
Projected CAGR
23%
The
compound annual growth rate
of Harmony Biosciences Holdings Inc's net income for the next 3 years is
23%.
